Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2879754rdf:typepubmed:Citationlld:pubmed
pubmed-article:2879754lifeskim:mentionsumls-concept:C0010453lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C0034721lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C0027882lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C0027908lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C0678558lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:2879754lifeskim:mentionsumls-concept:C0007512lld:lifeskim
pubmed-article:2879754pubmed:issue2lld:pubmed
pubmed-article:2879754pubmed:dateCreated1987-3-18lld:pubmed
pubmed-article:2879754pubmed:abstractTextWe have compared quantitatively the effects of muscle-conditioned medium (CM) and elevated K+ concentration (40 mM) on the enzymatic activity of tyrosine hydroxylase (TH) and on TH-mRNA levels in primary cultures of rat sympathetic neurons. Northern blot analysis of RNA from cultured neurons with a 32P-labeled rat TH-cDNA probe was performed. The probe hybridized strongly with a single RNA species of 1.9 kb, similar in size to the TH-mRNA from PC12 pheochromocytoma cells. In agreement with earlier data both CM and a partially purified factor from CM increased choline acetyltransferase activity up to 200-fold and depressed TH activity by 2- to 7-fold in cultured sympathetic neurons. These effects were accompanied by a decrease in TH-mRNA level, which correlated with the decrease in TH activity. On the other hand, a culture medium supplemented with 40 mM KCl caused a 1.5- to 5-fold increase in TH activity, which was accompanied by an increase in TH-mRNA level of the same order of magnitude. As a working hypothesis, we suggest that CM and neuronal depolarization control the transcription of the TH gene in an antagonistic manner.lld:pubmed
pubmed-article:2879754pubmed:languageenglld:pubmed
pubmed-article:2879754pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:citationSubsetIMlld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2879754pubmed:statusMEDLINElld:pubmed
pubmed-article:2879754pubmed:monthFeblld:pubmed
pubmed-article:2879754pubmed:issn0012-1606lld:pubmed
pubmed-article:2879754pubmed:authorpubmed-author:MalletJJlld:pubmed
pubmed-article:2879754pubmed:authorpubmed-author:Faucon-Biguet...lld:pubmed
pubmed-article:2879754pubmed:authorpubmed-author:WeberM JMJlld:pubmed
pubmed-article:2879754pubmed:authorpubmed-author:VidalSSlld:pubmed
pubmed-article:2879754pubmed:authorpubmed-author:RaynaudBBlld:pubmed
pubmed-article:2879754pubmed:issnTypePrintlld:pubmed
pubmed-article:2879754pubmed:volume119lld:pubmed
pubmed-article:2879754pubmed:ownerNLMlld:pubmed
pubmed-article:2879754pubmed:authorsCompleteYlld:pubmed
pubmed-article:2879754pubmed:pagination305-12lld:pubmed
pubmed-article:2879754pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:meshHeadingpubmed-meshheading:2879754-...lld:pubmed
pubmed-article:2879754pubmed:year1987lld:pubmed
pubmed-article:2879754pubmed:articleTitleThe use of a tyrosine-hydroxylase cDNA probe to study the neurotransmitter plasticity of rat sympathetic neurons in culture.lld:pubmed
pubmed-article:2879754pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2879754pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2879754pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2879754lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2879754lld:pubmed